PharmaShots Weekly Snapshots (Mar 29 - Apr 02, 2021)
Pfizer and BioNTech Report Results of BNT162b2 to Prevent COVID-19
Published: Apr 2, 2021 | Tags: Pfizer and BioNTech, Report, Results, BNT162b2, Prevent, COVID-19
Published: Apr 2, 2021 | Tags: Acceleron, Presents, Results, Sotatercept, P-II PULSAR Trial, Treatment, Pulmonary Arterial Hypertension
Published: Apr 2, 2021 | Tags: Revance, Presents, Results, DaxibotulinumtoxinA, Injection, P-III ASPEN-1 Trial, Treatment, Cervical Dystonia
Published: Apr 2, 2021 | Tags: Janssen and SpringWorks, Reports, Dosing, First, Patient, P-Ib Trial, Nirogacestat, Teclistamab, Treat, Relapsed or Refractory Multiple Myeloma
Published: Apr 2, 2021 | Tags: Kite, Reports, Submission, sBLA, US, FDA, Tecartus, Adult, Patients, R/R Acute Lymphoblastic Leukemia
Published: Apr 2, 2021 | Tags: BeyondSpring, Submits, NDA, US, FDA, China, NMPA, Plinabulin, Prevent, CT-Induced Neutropenia
Published: Apr 1, 2021 | Tags: Alnylam, Report, Results, Lumasiran, P-III ILLUMINATE-A Study, Primary Hyperoxaluria Type 1
Published: Apr 1, 2021 | Tags: Sanofi, Sarclisa (isatuximab-irfc), Carfilzomib, Dexamethasone, Receives, US, FDA, Approval, Treatment, R/R Multiple Myeloma
ADQ to Acquire Amoun Pharmaceutical from Bausch Health for ~$740M
Published: Apr 1, 2021 | Tags: ADQ, Acquire, Amoun Pharmaceutical, Bausch Health, ~$740M
Published: Apr 1, 2021 | Tags: Amryt, Reports, NDA, Submission, Oleogel-S10 (filsuvez), Treat, Cutaneous, Manifestations, Junctional, Dystrophic Epidermolysis Bullosa
Published: Apr 1, 2021 | Tags: BioXcel, Report, Results, BXCL501, P-Ib/II RELEASE Study, Treatment, Opioid Withdrawal Symptoms
BridgeBio Collaborates with Helsinn to Co- Develop and Commercialize Infigratinib in Oncology
Published: Apr 1, 2021 | Tags: BridgeBio, Collaborates, Helsinn, Co- Develop, Commercialize, Infigratinib, Oncology
Roche Launches Elecsys Epstein-Barr Virus (EBV) Immunoassay Panel to Identify EBV Infection Staging
Published: Mar 31, 2021 | Tags: Roche, Launches, Elecsys Epstein-Barr Virus (EBV) Immunoassay Panel, Identify, EBV Infection Staging
Amgen to Acquire Rodeo Therapeutics for ~$721M
Published: Mar 31, 2021 | Tags: Amgen, Acquire, Rodeo Therapeutics, ~$721M
Published: Mar 31, 2021 | Tags: Ipsen, Cabometyx, Opdivo, Receive, EC, Approval, 1L, Treatment, Patients, Advanced, Renal Cell Carcinoma
AbbVie Reports the US FDA's Acceptance of NDA for Atogepant as a Preventive Treatment for Migraine
Published: Mar 31, 2021 | Tags: AbbVie, Reports, US, FDA, Acceptance, NDA, Atogepant, Preventive, Treatment, Migraine
Merck to Acquire Alydia Health for ~$240M on Behalf of its Planned Spinoff of Organon
Published: Mar 31, 2021 | Tags: Merck, Acquire, Alydia Health, ~$240M, Behalf, Planned, Spinoff, Organon
Novartis In-Licenses Fibroblast Activation Protein (FAP) to Expand its Oncology Radioligand Pipeline
Published: Mar 31, 2021 | Tags: Novartis, In-Licenses, Fibroblast Activation Protein (FAP), Expand, Oncology, Radioligand, Pipeline
Published: Mar 30, 2021 | Tags: Novartis, Kesimpta (ofatumumab), Receives, EC, Approval, Adult, Patients, Relapsing Multiple Sclerosis
Cerecor Signs a Worldwide License Agreement with Kyowa Kirin for CERC-00
Published: Mar 30, 2021 | Tags: Cerecor, Signs, Worldwide, License Agreement, Kyowa Kirin, CERC-00
Published: Mar 30, 2021 | Tags: Eli Lilly, VIR and GSK, Report, Results, Bamlanivimab, VIR-7831, P-II BLAZE-4 Study, Low-Risk, Adults, COVID
Published: Mar 30, 2021 | Tags: Medtronic, Harmony Transcatheter Pulmonary Valve, Receives, US, FDA, Approval, Patients, Congenital Heart Disease
Published: Mar 30, 2021 | Tags: Roche and PTC, Evrysdi (risdiplam), Receive, EC, Approval, First, Only, Home, Treatment, Spinal Muscular Atrophy
Published: Mar 30, 2021 | Tags: Samsung Bioepis, Expand, Footprints, Launch, Hadlima (biosimilar, adalimumab), Australia, Canada
Published: Mar 29, 2021 | Tags: Roche, Tecentriq, Receives, CHMP, Positive Opinion, 1L, Treatment, Metastatic, Non-Small Cell Lung Cancer
Qiagen's NeuMoDx Multiplex Test Receives the US FDA's EUA and Expands its COVID-19 Portfolio
Published: Mar 29, 2021 | Tags: Qiagen, NeuMoDx Multiplex Test, Receives, US, FDA, EUA, Expands, COVID-19, Portfolio
GSK and VIR Report EUA Submission to the US FDA for VIR-7831 to Treat COVID-19
Published: Mar 29, 2021 | Tags: GSK and VIR, Report, EUA, Submission, US, FDA, VIR-7831, Treat, COVID-19
Helius Medical's PoNS Receives the US FDA's Approval to Improve Gait in Multiple Sclerosis Patients
Published: Mar 29, 2021 | Tags: Helius Medical, PoNS, Receives, US, FDA, Approval, Improve, Gait, Multiple Sclerosis Patients
Published: Mar 29, 2021 | Tags: GSK, Benlysta (belimumab), Receives, CHMP, Opinion, Recommending, Approval, Active, Lupus Nephritis
Published: Mar 29, 2021 | Tags: BMS and bluebird bio, Abecma (idecabtagene vicleucel), Receive, US, FDA, Approval, First, Anti-BCMA, CAR T Cell Therapy, R/R Multiple Myeloma
Related Post: PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com